sintx.com (SINT): Debts to Book Capitalization

Brandmark of sintx.com (SINT)

This chart of the total debt-to-equity ratio, with a metric value of 0.62, correlates with revenues from the sale of durable silicon nitride antibacterial components. Stable demand for specialized ceramics ensures the business's macro-stability. Sintx Technologies (SINT) is currently reviewing costs, shifting from retail implant sales toward expanding wholesale B2B supplies for medtech.

SINT - Sintx Technologies, Inc. Debts to Net Assets over the range 07/04/2022 - 10/27/2026
Original product of sintx.com

Sintx Technologies (SINT) ceramic production capacities correlate directly with the dynamics of the debt-to-equity ratio. This metric compares total liabilities to shareholders' equity, determining the business's degree of dependence on borrowed funds. This calculation reveals the balance between financial stability and aggressive growth. Moderate leverage is required for diversification into the aviation and medical sectors. Low values confirm high autonomy and asset quality.

Competitors of Sintx Technologies

BSX: Debts to Book Capitalization|Debts to Book Value edwards.com EW|RMD: Debts to Book Capitalization|PODD - Debt to Book Value|Zimmer Biomet - Debts to Book Capitalization|CooperSurgical (COO) - Debts to Net Assets|ALGN (Align Technology, Inc.) - Debts to Book Capitalization|Debts to Book Capitalization GMED|Debt to Book Capitalization Ratio TransMedics Organ Care System (TMDX)|Debt to Book Capitalization Ratio Alphatec Holdings (ATEC)|Debts to Book Capitalization AORT|ENOV - Debts to Net Assets|Debt to Book Value Integra LifeSciences|ESTA - Debts to Book Capitalization Ratio|Debts to Book Capitalization BBNX|IRADIMED Corp (IRMD) - Debts to Book Value|Debts to Book Capitalization Embecta Inc. (EMBC)|Debt to Book Value Ratio Tandem Corp (TNDM)|AxoGen, Inc. (AXGN) - Debt to Book Value|Debt to Net Assets Ratio SIBN (si-bone.com)|Orthofix - Debt to Book Capitalization Ratio|Debt to Book Value Bioventus Inc BVS|KIDS (OrthoPediatrics Inc.) - Debts to Book Capitalization|TMCI - Debts to Book Value|Debts to Book Capitalization Strata Critical Medical Inc|carlsmed.com (CARL) - Debt to Book Value Ratio|RXST: Debts to Book Capitalization|Debts to Net Assets ClearPoint|Debts to Book Capitalization STXS (Stereotaxis Corp)|Debt to Book Value Neuronetics, Inc (STIM)|Debts to Book Capitalization SGHT (Sight Sciences, Inc.)|Orchestra BioMed Inc. - Debts to Book Capitalization|ANIK - Debt to Book Capitalization Ratio|InspireMD Inc (NSPR) - Debt to Book Capitalization Ratio|Debt to Book Value zhjmedical.com ZJYL|Vivani Medical (VANI) - Debt to Net Assets Ratio|Debts to Book Capitalization XTNT (Xtant Medical Holdings, Inc.)|Debts to Book Value NMTC|MODD: Debt to Book Capitalization Ratio|Debt to Net Assets Myomo Inc. MYO|Debt to Book Value COCH (Envoy Medical, Inc)|Debts to Book Capitalization Vivos Therapeutics Inc VVOS|Debts to Book Capitalization NVNO (enVVeno Medical)|TNON: Debts to Net Assets|Debt to Book Capitalization Ratio Lifeward (LFWD)|AMIX (Autonomix Medical) - Debts to Book Capitalization Ratio|Debt to Book Capitalization Ratio IVF|Debt to Book Value Bone Biologics Inc|Axonics, Inc. - Debts to Book Capitalization|Debts to Book Value BIOL (biolase.com)|DYNT - Debt to Book Capitalization Ratio|FNA - Debt to Book Value Ratio|Debt to Book Value INVO Bio INVO